Exploring the level of efficacy of pelvic floor physiotherapy intervention for the treatment of Genitourinary Syndrome of Menopause (GSM) in women after the treatment of breast cancer

niversity of West Attica0 个研究点目标入组 60 人开始时间: 2022年6月15日最近更新: 2024年7月29日

适应症

试验速览

暂无简介。

•Women aged 35-65 years with :
•1. Pain during and/or after vaginal intercourse, greater than 7/10, based on the Visual Analogue Pain Scale (VAS).
•2. Also, women who have undergone immunosuppressive chemotherapy, received or are receiving adjuvant hormone therapy with tamoxifen (TAM), or aromatase inhibitors (AIs) and report symptoms of vaginal dryness and dyspareunia will also be included.
•3. Willing to be assigned to the study

•1. Metastatic breast cancer
•2. Vaginal or intravaginal stenosis
•3. Pelvic surgery
•4. Allergy to lubricating oils and moisturizers
•5. Women using hormone replacement therapy (HRT)
•6. Women who are on long-term use of birth control pills
•7. Women who are on some type of drug intervention for dyspareunia
•8. Diabetes
•9. Hypertension
•10. Obesity
•11. Hypothyroidism
•12. Urogynaecological infections
•13. Psychiatric conditions
•14. Vascular conditions
•15. In addition after enrollment, patients who present with difficulty understanding how to coordinate their pelvic floor muscles

发起方

niversity of West Attica